Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 EUR | +0.46% |
|
-0.68% | +35.94% |
Jul. 04 | French and Benelux stocks-Factors to watch on Friday | RE |
Jul. 03 | Waga Energy Secures 19-Year Term CAD 25 Million Loan to Refinance 3 RNG Production Units in Canada | CI |
Summary: Waga Energy
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Highlights: Waga Energy
- The prospective high growth for the next fiscal years is among the main assets of the company
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses: Waga Energy
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings Chart: Waga Energy
Source: Surperformance
Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
---|---|---|---|---|---|
- | - | 629M | |||
187M | |||||
Average | 407.86M | ||||
Weighted average by Cap. |
Investor (Composite)
-
Trader (Composite)
ESG MSCI
-
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
-
Valuation
P/E
-
EV/Revenue
EV/EBITDA
-
PBR
Dividend Yield
-
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- WAGA Stock
- Ratings Waga Energy
Select your edition
All financial news and data tailored to specific country editions